Envisagenics closes $2.35M seed round and launches SpliceCore Platform for identifying RNA targets from splicing errors

November 29, 2017 Leave a comment 4,633 Views

Envisagenics, Inc., a biotechnology company that applies Artificial Intelligence to the genetic sequence of patients to discover new therapies, announced today that is has raised $2.35M in its seed round. The investors include Third Kind Venture Capital (3KVC), Cosine, LLC ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Cosine

Envisagenics closes $2.35M seed round and launches SpliceCore Platform for identifying RNA targets from splicing errors

DCoNA – a tool for fast differential correlation network analysis

SpliceVault – predicting the precise nature of variant-associated mis-splicing

High-throughput droplet-based analysis of influenza A virus genetic reassortment by single-virus RNA sequencing

The way genes are switched on in one-cell embryos may resemble the trigger for cancer

scONE-seq – A single-cell multi-omics method enables simultaneous dissection of phenotype and genotype heterogeneity from frozen tumors

Phasik – inferring cell cycle phases from a partially temporal network of protein interactions

Single-cell transcriptomic profiling of Crohn’s disease reveals a detailed picture of inflammation in the gut